Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E A Poplin

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Cancer|January 15, 1991
A dose-intensive regimen of 5-fluorouracil for the treatment of metastatic colorectal carcinomaE A Poplin, M Kraut, L Baker, et al.
Cancer|July 1, 1991
Pneumocystis carinii pneumonia in patients with solid tumors without acquired immune deficiency syndromeE A Poplin, C J Gordon, T J Piskorowski, et al.
Investigational New Drugs|January 1, 1994
Hepatoma/merbarone. A Southwest Oncology Group studyE A Poplin, C M Tangen, W H Harvey, et al.
Federation Proceedings|August 1, 1974
Selective immunosuppression by drugs in balanced immune responsesG H Heppner, D E Griswold, J Di Lorenzo, et al.
Cancer Treatment Reports|July 1, 1982
CCNU, vincristine, methotrexate, and procarbazine treatment of relapsed small cell lung carcinomaE A Poplin, J Aisner, D A Van Echo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 18, 2001
Mortality associated with irinotecan plus bolus fluorouracil/leucovorin: summary findings of an independent panelM L Rothenberg, N J Meropol, E A Poplin, et al.
Investigational New Drugs|February 1, 1991
Crisnatol mesylate: phase I dose escalation by extending infusion durationE A Poplin, G G Chabot, R L Tuttle, et al.
Investigational New Drugs|August 1, 1992
Difluorodeoxycytidine (dFdC)--gemcitabine: a phase I studyE A Poplin, T Corbett, L Flaherty, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1994
GM-CSF, carboplatin, doxorubicin: a phase I studyE A Poplin, D S Alberts, J J Rinehart, et al.
Cancer|November 1, 1996
Evaluation of multimodality treatment of locoregional esophageal carcinoma by Southwest Oncology Group 9060E A Poplin, J Jacobson, A Herskovic, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Cancer|January 15, 1991
A dose-intensive regimen of 5-fluorouracil for the treatment of metastatic colorectal carcinomaE A Poplin, M Kraut, L Baker, et al.
Cancer|July 1, 1991
Pneumocystis carinii pneumonia in patients with solid tumors without acquired immune deficiency syndromeE A Poplin, C J Gordon, T J Piskorowski, et al.
Investigational New Drugs|January 1, 1994
Hepatoma/merbarone. A Southwest Oncology Group studyE A Poplin, C M Tangen, W H Harvey, et al.
Federation Proceedings|August 1, 1974
Selective immunosuppression by drugs in balanced immune responsesG H Heppner, D E Griswold, J Di Lorenzo, et al.
Cancer Treatment Reports|July 1, 1982
CCNU, vincristine, methotrexate, and procarbazine treatment of relapsed small cell lung carcinomaE A Poplin, J Aisner, D A Van Echo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 18, 2001
Mortality associated with irinotecan plus bolus fluorouracil/leucovorin: summary findings of an independent panelM L Rothenberg, N J Meropol, E A Poplin, et al.
Investigational New Drugs|February 1, 1991
Crisnatol mesylate: phase I dose escalation by extending infusion durationE A Poplin, G G Chabot, R L Tuttle, et al.
Investigational New Drugs|August 1, 1992
Difluorodeoxycytidine (dFdC)--gemcitabine: a phase I studyE A Poplin, T Corbett, L Flaherty, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1994
GM-CSF, carboplatin, doxorubicin: a phase I studyE A Poplin, D S Alberts, J J Rinehart, et al.
Cancer|November 1, 1996
Evaluation of multimodality treatment of locoregional esophageal carcinoma by Southwest Oncology Group 9060E A Poplin, J Jacobson, A Herskovic, et al.
Pageof 2